Nuventra Pharma Sciences, a United States-based clinical pharmacology consulting company, has named Daniel Roy, MHA as its new president, it was reported on Tuesday.
Roy joined the company in 2014 as manager of Marketing and Corporate Communication. He has served in various roles of increasing responsibility including senior director of Business Development and Marketing, and most recently as vice president of Corporate Strategy and Business Development. He has 16 years of experience in leadership, marketing, and business development. He will continue to serve as the company's chief executive officer.
Roy graduated from Ohio University with a Master of Healthcare Administration and acquired a Bachelor of Arts degree in Communication from East Carolina University.
GelMEDIX completes USD13m seed financing, announces first partnership
AmacaThera named Life Sciences Ontario Emerging Company of the Year
GenSight Biologics reports first patient treated in GS010 REVISE study
Biophytis secures Asian partnership and investment to advance Phase 3 sarcopenia programme
MemorialCare hospitals recognised in 2026 Women's Choice Awards
Champions Oncology expands bioanalytical services with new technology and leadership
PhaseV receives three industry honours for AI in clinical development
Galapagos plans to wind down cell therapy business following strategic review
Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025
Revelation Pharma acquires Acacia Apothecary & Wellness
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers